CPhI Show Daily Podcast Series - Valsynthese - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhI Show Daily Podcast Series - Valsynthese


Valsynthese - Mr. Helmut Zimmerman


Helmut Zimmermann
Commercial Director
Valsynthese

Add this Podcast feed to your media player



Valsynthese is a custom manufacturing organisation concentrating on hazardous and high energetic chemistry. Mr. Zimmermann introduces Valsynthese’s new capabilities in phosgenation, further expanding their tool-box of core competencies in highly energetic reactions. Mr. Zimmerman also delivers quality system updates as well as future plans for compliance beyond approval as API manufacturers in Europe, Asia, South America and Japan. Reducing environmental impact through investment in new recycling facilities is also discussed.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here